每周股票复盘：拱东医疗（605369）发布“提质增效重回报”行动方案

Core Viewpoint - Gongdong Medical (605369) has implemented a "Quality Improvement and Efficiency Enhancement" action plan aimed at upgrading its core business and enhancing investor returns, which includes measures in R&D, production, market expansion, and dividend policies [1] Company Announcement Summary - Gongdong Medical's stock closed at 18.81 yuan on December 26, 2025, reflecting a 1.46% increase from the previous week's closing price of 18.54 yuan [1] - The stock reached a peak price of 19.4 yuan on December 25, 2025, and a low of 18.06 yuan on December 23, 2025 [1] - The company's current total market capitalization is 4.147 billion yuan, ranking 84th out of 127 in the medical device sector and 3839th out of 5178 in the A-share market [1] - The "Quality Improvement and Efficiency Enhancement" action plan includes increased R&D investment, promotion of intelligent production, expansion into domestic and international markets, improvement of corporate governance, enhanced information disclosure, and implementation of stable dividends [1] - The plan aims to protect investor rights but does not constitute a substantive commitment to investors, indicating inherent uncertainties [1]